Effect of Preoperative Administration of Intravenous Ferric Carboxymaltose in Patients with Iron Deficiency Anemia after Off-Pump Coronary Artery Bypass Grafting: A Randomized Controlled Trial
Journal of Clinical Medicine · 21.02.2023 · 12 (5) · 1737
DOI: 10.3390/jcm12051737 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 21.02.2023. Verfasst von Hyo-Hyun Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Ilsan Hospital, National Health Insurance Service, Goyang-si 10444, Republic of Korea. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JW Pharmaceutical and Vifor Pharma.
Abstract (Originalsprache)
Patients scheduled for cardiac surgery often have anemia and iron deficiency. We investigated the effect of the preoperative administration of intravenous ferric carboxymaltose (IVFC) in patients with iron deficiency anemia (IDA) who were due to undergo off-pump coronary artery bypass grafting (OPCAB). Patients who were due to undergo elective OPCAB between February 2019 and March 2022 who had IDA (n = 86) were included in this single center, randomized, parallel-group controlled study. The participants were randomly assigned (1:1) to receive either IVFC or placebo treatment. Postoperative hematologic parameters [hemoglobin (Hb), hematocrit, serum iron concentration, total iron-binding capacity, transferrin saturation, transferrin concentration, and ferritin concentration] and the changes in these parameters during the follow-up period were the primary and secondary outcomes, respectively. The tertiary endpoints were early clinical outcomes, such as the volume of mediastinal drainage and the need for blood transfusions. IVFC treatment significantly reduced the need for red blood cell (RBC) and platelet transfusions. Despite receiving fewer RBC transfusions, patients in the treatment group had higher levels of Hb, hematocrit, and serum iron and ferritin concentrations during weeks 1 and 12 after surgery. No serious adverse events occurred during the study period. Preoperative IVFC treatment in patients with IDA undergoing OPCAB improved the values of the hematologic parameters and iron bioavailability. Therefore, is a useful strategy for stabilizing patients prior to OPCAB.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, Ilsan Hospital, National Health Insurance Service, Goyang-si 10444, Republic of Korea.
- Division of Cardiovascular Surgery, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Yonsei University Health System, Seoul 03722, Republic of Korea.
ORCID-Profile: Hyo-Hyun Kim, Eun Hye Park, Young-Nam Youn
Förderung
- JW Pharmaceutical and Vifor Pharma
Zitieren
APA
Kim, H. H., Park, E. H., Lee, S. H., Yoo, K. J., & Youn, Y. N. (2023). Effect of Preoperative Administration of Intravenous Ferric Carboxymaltose in Patients with Iron Deficiency Anemia after Off-Pump Coronary Artery Bypass Grafting: A Randomized Controlled Trial. Journal of Clinical Medicine, 12(5), 1737. https://doi.org/10.3390/jcm12051737
Vancouver
Kim HH, Park EH, Lee SH, Yoo KJ, Youn YN. Effect of Preoperative Administration of Intravenous Ferric Carboxymaltose in Patients with Iron Deficiency Anemia after Off-Pump Coronary Artery Bypass Grafting: A Randomized Controlled Trial. Journal of Clinical Medicine. 2023;12(5):1737. doi:10.3390/jcm12051737
BibTeX
@article{Kim2023,
author = {Kim, Hyo-Hyun and Park, Eun Hye and Lee, Seung Hyun and Yoo, Kyung-Jong and Youn, Young-Nam},
title = {Effect of Preoperative Administration of Intravenous Ferric Carboxymaltose in Patients with Iron Deficiency Anemia after Off-Pump Coronary Artery Bypass Grafting: A Randomized Controlled Trial},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {5},
pages = {1737},
doi = {10.3390/jcm12051737}
}
EUVIMED